Renal Anhydramnios Fetal Therapy (RAFT) Trial
肾性羊水不足胎儿治疗 (RAFT) 试验
基本信息
- 批准号:10378754
- 负责人:
- 金额:$ 65.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Abruptio PlacentaeAddressAffectAmericanAmniocentesisAmniotic FluidAmniotic Fluid EmbolismBilateralBiological MarkersBirthCase StudyCessation of lifeChildChildhoodChronicClinicalDataData Coordinating CenterDecision MakingDiagnosisDialysis procedureDiseaseEarly DiagnosisEducational workshopEligibility DeterminationEquipment and supply inventoriesExclusion CriteriaFamilyFeasibility StudiesFetal DiseasesFetal LungFetal safetyFetusFirst Pregnancy TrimesterGoalsGrowthHeadHemodialysisHemorrhageHospitalsImpairmentInfantInfusion proceduresInstitutional Review BoardsInterventionKidneyKidney FailureKidney TransplantationKnowledgeLettersLightLungMagnetic Resonance ImagingMaternal complicationMeasurementMeasuresModelingMulti-Institutional Clinical TrialNational Institute of Child Health and Human DevelopmentNational Institute of Diabetes and Digestive and Kidney DiseasesNatural HistoryNeonatalOutcomeOxygenParentsPatientsPeritoneal DialysisPregnancyPremature BirthPremature LaborProspective StudiesProteomicsProtocols documentationPublishingPulmonary artery structureQuality of lifeRadiology SpecialtyRenal TissueRenal functionReportingRespiratory FailureRespiratory physiologySafetySalineSecondary toSiteStressSurvivorsTechniquesTestingTherapy trialToddlerTransplantationTreatment EfficacyUnited StatesUrinary tractUrineUterine RuptureWomanWorkbaseclinical practicecohortcongenital anomalies of the kidneyearly onsetearly pregnancyefficacy studyexperiencefetalhealth goalsimprovedin uteroinclusion criteriainnovationintraamniotic infectionlipidomicsliving kidney donorlung developmentlung preservationlung volumematernal safetyneonatal periodneonatenovelpilot trialpost-transplantpostnatalprenatalprenatal therapypreterm premature rupture of membranesprospectivepulmonary functionpulmonary hypoplasiarenal agenesissafety and feasibilitysafety studytreatment strategyultrasound
项目摘要
Summary
The goal of this proposal is to evaluate the safety, feasibility and efficacy of serial amnioinfusions, a novel fetal
therapy for early pregnancy renal anhydramios (EPRA). EPRA occurs in more than 1 in 2000 pregnancies and
affects 1500 families in the U.S annually. EPRA has previously been considered universally fatal due to its
associated pulmonary hypoplasia and neonatal respiratory failure. More recently, preliminary data from case
reports have demonstrated an association between serial amnioinfusion therapy and short-term postnatal
survival in EPRA fetuses, with excellent respiratory function in the neonatal period. Furthermore, long-term
survival has been observed in a few cases, largely due to advances in neonatal dialysis and the advent of safe
living donor kidney transplantation in toddlers. Serial amnioinfusions for the management of EPRA have been
implemented in clinical practice, but no systematic and prospective study evaluating this treatment has
occurred. Therefore, there is a lack of generalizable knowledge about the maternal/fetal safety, feasibility and
short- and long-term clinical outcomes of this intervention. This proposal to study Renal Anhydramnios Fetal
Therapy (RAFT) consists of a multi-center, non-randomized prospective trial to address the following specific
aims: (1) To determine the maternal and fetal safety and feasibility of serial amnioinfusions for EPRA
(2) To examine the short-term efficacy of RAFT and (3) To determine the long-term efficacy of RAFT on
survival and quality of life. A consortium of 8 advanced fetal centers will operate under a single institutional
review board with one protocol that has strict inclusion and exclusion criteria. Each center has been selected
based on long experience and expertise in advanced fetal therapy and neonatal dialysis. This pilot trial will also
seek to elucidate the mechanism of RAFT by capturing radiologic and amniotic fluid biomarkers during therapy.
Furthermore, it will permit the first prospective analysis of the in utero natural history of EPRA by rigorously
tracking patients who do not terminate their EPRA pregnancy but do not wish to undergo serial amnioinfusions.
The RAFT trial not only has the potential to improve our understanding of the effect of serial amnioinfusions on
lung growth in EPRA but also on other fetal diseases that impair lung function. Furthermore, serial
amnioinfusions in EPRA pregnancies and serial acquisition of amniotic fluid biomarkers along with assessment
of radiologic biomarkers may shed new light on the mechanisms of normal lung development. Most
importantly, this trial will provide crucial data to assist families in making decisions about fetal therapy for
fetuses affected by EPRA, making incremental progress toward the goal of health from birth for all children.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meredith Ann Atkinson其他文献
Meredith Ann Atkinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Meredith Ann Atkinson', 18)}}的其他基金
Renal Anhydramnios Fetal Therapy (RAFT) Trial
肾性羊水不足胎儿治疗 (RAFT) 试验
- 批准号:
10596533 - 财政年份:2020
- 资助金额:
$ 65.23万 - 项目类别:
Hepcidin and Anemia in Children: Mechanisms and Modifiers
铁调素和儿童贫血:机制和调节因素
- 批准号:
8494040 - 财政年份:2011
- 资助金额:
$ 65.23万 - 项目类别:
Hepcidin and Anemia in Children: Mechanisms and Modifiers
铁调素和儿童贫血:机制和调节因素
- 批准号:
8688226 - 财政年份:2011
- 资助金额:
$ 65.23万 - 项目类别:
Hepcidin and Anemia in Children: Mechanisms and Modifiers
铁调素和儿童贫血:机制和调节因素
- 批准号:
8111549 - 财政年份:2011
- 资助金额:
$ 65.23万 - 项目类别:
Hepcidin and Anemia in Children: Mechanisms and Modifiers
铁调素和儿童贫血:机制和调节因素
- 批准号:
8262155 - 财政年份:2011
- 资助金额:
$ 65.23万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 65.23万 - 项目类别:
Research Grant